Front Row Advisors’s Edwards Lifesciences EW Stock Holding History

Front Row Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.69K	Hold	96	–	–	﹤0.01%	415
2025 Q4	$8.18K	Hold	96	–	–	﹤0.01%	406
2025 Q3	$7.47K	Sell	96 -48	-33%	-$3.75K	﹤0.01%	415
2025 Q2	$11.3K	Sell	144 -96	-40%	-$7.16K	﹤0.01%	358
2025 Q1	$17.4K	Hold	240	–	–	0.01%	304
2024 Q4	$17.8K	Hold	240	–	–	0.01%	308
2024 Q3	$15.8K	Hold	240	–	–	0.01%	317
2024 Q2	$22.2K	Hold	240	–	–	0.01%	401
2024 Q1	$22.9K	Hold	240	–	–	0.01%	391
2023 Q4	$18.3K	Hold	240	–	–	0.01%	271
2023 Q3	$16.6K	Hold	240	–	–	0.01%	420
2023 Q2	$23K	Hold	240	–	–	0.01%	346
2023 Q1	$20K	Buy	+240	New	+$18.9K	0.01%	374
2022 Q4	–	Sell	-240	Closed	-$18.5K	–	896
2022 Q3	$20K	Hold	240	–	–	0.01%	380
2022 Q2	$23K	Hold	240	–	–	0.01%	356
2022 Q1	$28K	Hold	240	–	–	0.01%	337
2021 Q4	$31K	Hold	240	–	–	0.01%	332
2021 Q3	$27K	Hold	240	–	–	0.01%	351
2021 Q2	$28K	Hold	240	–	–	0.01%	348
2021 Q1	$20K	Hold	240	–	–	0.01%	403
2020 Q4	$22K	Hold	240	–	–	0.01%	366
2020 Q3	$20K	Sell	240 -372	-61%	-$29K	0.01%	380
2020 Q2	$42K	Sell	612 -375	-38%	-$26.6K	0.03%	238
2020 Q1	$72K	Buy	987 +747	+311%	+$53.9K	0.05%	172
2019 Q4	$19K	Hold	240	–	–	0.01%	337
2019 Q3	$18K	Hold	240	–	–	0.01%	339
2019 Q2	$15K	Hold	240	–	–	0.01%	361
2019 Q1	$15K	Buy	+240	New	+$13.7K	0.01%	374

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Front Row Advisors's EW Position: Q1 2026 in Review

Front Row Advisors held its Edwards Lifesciences (EW) position steady in Q1 2026 at 96 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #415.

Front Row Advisors first reported a position in EW in Q1 2019 and has held it in 28 quarters since. The position peaked at $72K in Q1 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Front Row Advisors held 96 shares of Edwards Lifesciences worth $7.69K as of Q1 2026.
Front Row Advisors left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #415 holding.
Front Row Advisors first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 28 quarters since.
Front Row Advisors's Edwards Lifesciences position peaked at $72K in Q1 2020.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.